FDA Inspection 1295318 — Amar Dodda
The FDA completed an inspection of Amar Dodda on December 5, 2025 in Tomball, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 5, 2025
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Tomball, TX (United States)
Additional Details
Clinical Investigator (CI)